Skip to main content

Published locations for ‘Practice Changing’ Results for Osimertinib in Unresectable Stage III EGFR+ NSCLC

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. ‘Practice Changing’ Results for Osimertinib in Unresectable Stage III EGFR+ NSCLC

User login

  • Reset your password
  • /content/practice-changing-results-osimertinib-unresectable-stage-iii-egfr-nsclc
  • /oncologypractice/article/269481/lung-cancer/practice-changing-results-osimertinib-unresectable-stage
  • /hematology-oncology/article/269481/lung-cancer/practice-changing-results-osimertinib-unresectable
  • /chestphysician/article/269481/lung-cancer/practice-changing-results-osimertinib-unresectable-stage